(19)

(11)

EP 4 562 184 A2

(12)

(88) Date of publication A3: 07.03.2024 (43) Date of publication: 04.06.2025 Bulletin 2025/23 (21) Application number: 23847625.3 (22) Date of filing: 31.07.2023

(51) International Patent Classification (IPC):  C12Q 1/6883(2018.01) A61P 25/28(2006.01) G16H 10/40(2018.01) A61B 5/145(2006.01) G16B 20/20(2019.01) (52) Cooperative Patent Classification (CPC): C12Q 1/6883; C12Q 2600/158; C12Q 2600/106; G16H 20/10; G16H 10/40; G16H 50/30; G16B 25/10; G16B 5/00; G16B 20/00 (86) International application number: PCT/US2023/071350 (87) International publication number: WO 2024/026509 (01.02.2024 Gazette 2024/05)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 29.07.2022 US 202263393573 P 26.06.2023 US 202363523281 P (71) Applicant: Anavex Life Sciences Corp. New York, NY 10111 (US)	(72) Inventor: MISSLING, Christopher U. New York, New York 10111 (US) (74) Representative: SONN Patentanwälte GmbH & Co KG  Riemergasse 14 1010 Wien 1010 Wien (AT)